Director, Patient Centered Outcomes Research, Oncology

About Abb Vie Abb Vie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about Abb Vie, please visit us at  Follow on Linked In, Facebook, Instagram, X and You Tube.

The Director, Patient Centered Outcomes Research, is responsible for the design and execution of strategically-focused and innovative patient experience data (PED) evidence to support optimization of product registration, access & reimbursement, and clinical practice in collaboration with HEOR Strategy and other functions (eg, Clinical Development & Operations, Regulatory, Commercial).

The Director, Patient-Centered Outcomes Research, will support Oncology primarily and cultivate strong partnerships to enable effective cross-functional collaboration with other product team members from internal groups including HEOR-Strategy, Clinical Development and Operations, Biostatistics, Regulatory Affairs, Medical Affairs, and the Commercial organization. The Director represents HEOR at global regulatory and payer / HTA meetings and may lead and/or support negotiations in collaboration with cross-functional team members to drive internal strategy and alignment with global regulatory & reimbursement agencies.

In addition, the Director will represent Abb Vie externally and assume a leadership role in collaborations with external partners (eg, industry consortiums, key opinion leaders, research organizations, patient advocacy groups). He / She serves as a subject matter expert (SME) on PED and patient-centered measurement strategies within HEOR and Abb Vie to drive a patient-centric culture and adoption/uptake of standards and best practices for PED.

The Director will oversee at least one therapeutic area (eg, oncology, rheumatology, gastroenterology, dermatology, neurosciences, eye care, aesthetics) and their responsibility will span multiple products/ indications. Additional responsibilities for the Director include developing annual strategic planning of PED aligned with TA / asset strategy and managing multiple projects and vendors to execute PED for their respective TA responsibilities.

Managerial responsibilities may include attracting, mentoring, and oversight of junior members of the team (eg, interns, fellows, associate directors); development of annual strategic plans aligned with TA / asset strategy and managing annual budgets for their respective TA responsibilities.

Responsibilities

• Responsible for execution of global PED generation and stakeholder engagement strategies that encompasses innovative research aligned with overall asset strategy across multiple therapeutic areas
• Leads management of projects to ensure timely execution ofPED research to characterize patient outcomes, identify patient preferences and unmet needs, inform patient-focused measurement strategies, and develop and validate innovative patient-relevant outcomes measures and endpoints to differentiate Abb Vie’s portfolio and meet business and global needs
• Supports alignment of strategy with HEOR-Strategy counterparts and communicates strategy and translates results cross-functionally to key cross-functional teams that are part of Pipeline Commercial Model to facilitate alignment and integration of PED plans into the broader Integrated Evidence Plans
• Ensures the scientific quality and integrity of COA research through development of rigorous qualitative and quantitative study research proposals, protocols, analysis plans and reports
• Leads integration of COA measurement strategy into clinical development programs through clinical trial program support (eg, protocol/SAP content development, results interpretation, and CSR development) and ensures appropriate implementation of COAs on eCOA platforms in global programs
• Leads development, validation, and implementation of COAs measures for randomized controlled trials (RCTs) / observational…